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Abstract
Background: Despite the high prevalence of sexually transmitted infections (STIs) and HIV
infection in US correctional settings, most jails and prisons in the United States prevent inmates
from using condoms to prevent STIs/HIV.
Discussion: This article makes the following arguments to justify a scalable and feasible next step
in the prevention of HIV/STIs among inmates: condoms are a basic and essential part of HIV/STI
prevention, HIV/STI transmission occurs in the context of corrections, and several model programs
show the feasibility of condom distribution in prisons. A lower end estimate for HIV incidence
among incarcerated applied to 2,000,000 new inmates annually results in thousands of new HIV
infections acquired each year in corrections that could be prevented with condoms in corrections
facilities. Programs from parts of the United States, Canada, and much of Europe show how
programs distributing condoms in correctional facilities can be safe and effective.
Summary: Public health and corrections officials must work together to ensure that condoms and
broader sexual disease prevention programs are integrated into US jail and prison health systems.
Background
"Orr would be crazy to fly more missions and sane if he
didn't, but if he was sane he had to fly them. If he flew
them he was crazy and didn't have to; but if he didn't want
to he was sane and had to."
-Catch-22, Joseph Heller
A US prison medical provider would be reasonable to give
an inmate a condom to prevent HIV and sexually trans-
mitted infections (STIs) but doing so would acknowledge
that unprotected sex and sexual HIV transmission occur in
jails and prisons. Current policies in the vast majority of
US prisons hold that sex in prison is illegal and condoms
are contraband. This is the Catch-22 of condoms in US
prisons and jails. The data connecting prisoners to both
higher seroprevalence of HIV/STI [1] and HIV seroconver-
sion from sex during incarceration [2] is clear; condoms
are similarly well understood to prevent HIV/STIs.
Although public health experts and physicians have called
for more attention to HIV/STI treatment and prevention
in jails and prisons [3], a plan of action and detailed
account of successful programs has not emerged. This arti-
cle makes the following arguments to justify a scalable
and feasible next step in the prevention of HIV/STIs
among inmates: condoms are a basic and essential part of
HIV/STI prevention, HIV/STI transmission occurs in the
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context of corrections, and several model programs show
the feasibility of condom distribution in prisons.
Discussion
The importance of condoms for sexual HIV prevention
among inmates and within correctional settings has been
known for some time [4,5]. Condoms are a core compo-
nent of basic HIV prevention services recommended by
the US Centers for Disease Control and the World Health
Organization [6,7]. The WHO recommendations on HIV
in prisons specifically calls for widespread condom avail-
ability for all inmates [8]. The Institute of Medicine has
argued for expanded STI services among disadvantaged
populations [9]. The Institute recommended that deten-
tion facilities provide comprehensive STI-related services,
including counseling and education, screening, diagnosis
and treatment, partner notification and treatment, as well
as methods for reducing unprotected sex.
Several studies highlight that unprotected sex facilitates
HIV and STI transmission in correctional settings [10-16].
Seroprevalence data indicate that HIV seroprevalence
among incarcerated individuals is fivefold greater than the
seroprevalence among the general population [17]. Most
HIV positive inmates enter the correctional system with
infection, and do not acquire it during incarceration. Lack
of testing upon entry or release in prisons obscures the
extent to which HIV negative inmates acquire HIV during
prison stays. There are currently 19 states with mandatory
HIV testing on entry, and Centers for Disease Control data
from one state (Georgia) recently investigated HIV sero-
conversion in correctional settings. In a study of 17 years
of HIV testing data, 88 HIV positive individuals who sero-
converted during incarceration were identified [2].
Although this corresponds to a low incidence of HIV
infection in prisons, the number of individuals diagnosed
with new HIV infections in prison settings is heavily influ-
enced by testing policies. The majority of new HIV infec-
tions in the Georgia corrections system were discovered
during a period when voluntary annual HIV testing was
available to inmates. In other studies, even after control-
ling for the six-month window period between infection
and serologic detection, annual HIV transmission rates in
prison ranged from 0.3 to 0.63 percent [10-13]. The lower
end estimate for HIV incidence among incarcerated
(0.3%) among 2,000,000 new inmates annually [17]
results in 6,000 new HIV infections acquired each year in
corrections that could be prevented with condoms in cor-
rections facilities. Outbreaks of syphilis [14,18], gonor-
rhea [19], and Hepatitis B[15,16] in prisons provide
further support that unprotected sex occurs in jails and
prisons. Studies of sexual behaviors in prisons are limited
by recall bias and confidentiality, but similarly show high
risk behaviors occurring in prisons and jails [4].
Analyzing the critiques of condom distribution in prison
is essential to understanding current correctional HIV pre-
vention policy. As the 1990s saw major developments in
HIV law outside of the US permitting use of condoms in
prisons and jails, concerns about transport of contraband
and use of condoms as weapons plagued American correc-
tional facilities. These hesitations about the safety, accept-
ability, and feasibility of providing condoms to prisoners
have been addressed by successful model programs in
many US cities and states (San Francisco, District of
Columbia, Los Angeles, Philadelphia, parts of NYC, Mis-
sissippi, Vermont) [20]. For example, most correctional
officers and inmates at the Washington, DC jail, which
has provided condoms in jails over ten years, favored con-
dom distribution. The majority of inmates felt there was
no increase in sexual activity as a result of condom availa-
bility. In addition, the vast majority (87%) of correctional
officers reported no problems with this policy [20]. While
these US cities and states provide experience to support
condom distribution, these programs are dwarfed in
breadth and depth by other country's programs.
Large scale national programs making condoms available
in prisons have been present in Canada and many Euro-
pean nations for over a decade. The proportion of Euro-
pean prison systems allowing condoms rose from 53% in
1989 to 81% in 1997 [21]. More importantly, none of the
penal systems that have introduced condom distribution
have reversed their policy, and the number of correctional
facilities with condoms grows each year. The Canadian
HIV/AIDS Legal Network and the Canadian AIDS Society
argued early in the 1990s for more widespread condom
availability independent of inmates asking for them [21].
This policy was adopted by the Canadian government,
and has proven feasible and effective [22]. Canadian law
now guarantees that condoms be available in three dis-
crete unique locations in the prison, in addition to being
provided for conjugal visits [23]. In Australia, 50 prisoners
brought legal action against the state for non-provision of
condoms, prompting the provision of condoms in New
South Wales. This policy has since been found effective
and sustainable [24]. Stigma associated with obtaining
condoms in prison environments did not limit the utility
of the program since condoms were available in multiple
locations without asking a physician; such measures
would be important to ensuring that the stigma associated
with homosexual behaviors often found in correctional
settings does not limit opportunities for HIV prevention.
The increasing number of international jails and prisons
distributing condoms provides useful information about
structuring scalable successful programs.
Summary
Basic HIV prevention services only begin with the wide-
spread availability of condoms. While the stigma associ-
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ated with homosexual behaviors and condom use in
prisons would be difficult to change, providing prisoners
direct access to condoms could serve to limit the stigma
attached to these risk behaviors. Security, medical and
public health groups must collaborate to form policy
introducing condoms, HIV education, and comprehen-
sive STD screening in jails and prisons. Experiences from
several parts of the US, Canada, and much of Europe show
that condoms can safely and effectively prevent STIs in
prisons. Leverage from lawyers and activists to character-
ize how prisoners are currently denied their right to the
most basic HIV prevention tools may help serve to cata-
lyze change. State and national politicians in the US have
identified this as important issue worthy of legislative
action. Neither federal [25] nor statewide[26] legislative
efforts have successfully resolved the Catch-22 of ensuring
condom access among incarcerated individuals in the
United States. Public health and corrections officials must
work together to ensure that condoms and broader sexual
disease prevention programs are integrated into US jail
and prison health systems.
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